Skip to main content

Conference on teaching art to the blind/visually impaired

I"m not sure how I got on the mailing list for this event, but man, I wish I could go. It sounds very cool. Since many readers are interested in topics concerning low vision/blindness etc. I thought perhaps someone would be interested. If you go, you HAVE to let me know about it.


Dear Friends and Colleagues,

If you have any questions about this event please contact the Metropolitan Museum of Art not CCVIP. Please pass this on.

Thank you for your support.

Lisa F. Saunders
Marketing Assistant, CCVIP


From: Gunther, Christena [
mailto:Christena.Gunther@metmuseum.org]
Subject: Art Beyond Sight: Multimodal Approaches to Learning International Conference at The Met Museum, Oct. 16 and 17

Time is running out to register for the Art Beyond Sight Conference on October 16 and 17 at The Metropolitan Museum of Art. Register today! Special student rates and student group rates are available.

Art Beyond Sight: Multimodal Approaches to Learning An International Conference

October 16 and 17, 2009

Co-sponsored by Art Education for the Blind & The Metropolitan Museum of Art

Location: The Metropolitan Museum of Art , 1000 Fifth Avenue , New York City

This conference will address the challenges faced by educators, artists, museum professionals, architects and designers to create learning opportunities and inclusive learning environments that better serve all audiences, and meet the needs of learners with sensory impairment or those who use different learning styles.

The conference will showcase best practices in classroom and museum education, as well as pioneering approaches to learning, exhibition and program design. The multidisciplinary plenary sessions that are a trademark of the Art Beyond Sight conferences will feature art historians, anthropologists, curators, neuroscientists, new media and Universal Design experts, architects and educators, who will present their diverse perspectives on disability, the senses, art and education. In addition to plenary sessions, concurrent sessions will include discussions and thought-provoking cross-disciplinary dialog focused on issues of education program design, product design, new technology and the senses, museums and learning environments in the 21st century, among other topics.

Schedule Highlights Available:
http://www.artbeyondsight.org/docs/ScheduleHighlights2009.doc
Speakers include: David Howes, Concordia University; Constance Classen, Concordia University; Pawan Sinha, MIT Harvard; Alvaro Pascual-Leone, MIT Harvard; Barbara Tversky, Teachers College/Columbia University; Lotfi Merabet, MIT Harvard; Richard Sandell, University of Leicester; Georgina Kleege, University of California, Berkeley; Gordon Legge, University of Minnesota; Madalina Diaconu, University of Vienna (Austria); Patrick Devlieger, University of Leuven (Belgium); Carlos Mourão Pereira, architect (Portugal); Valerie Fletcher, Institute for Human Centered Design (MA)

There will also be Poster sessions during the conference and optional events and museum tours on Sunday, October 18.

Registration: The official registration form and additional information is posted on
www.artbeyondsight.org/change/aw-conference-2009.shtml. If you wish to have the form emailed to you, send your name and email address to: aeb@artbeyondsight.org; with "October Conference" in the subject line.

Conference Fees:
Full conference (2 days) *
$200 ($130 for students/ID required)

One-day attendance *
$100 ($65 for students/ID required)

Student Group Rate (8 or more students) * Full Conference (2 days): $110 One day: $55

*Please note: People who register after September 13, 2009, may be asked to sit in an overflow room during plenary sessions. The talks will be broadcast in real time, and audience members will be able to participate in the discussions.


Access Coordination
The Metropolitan Museum of Art
1000 Fifth Avenue New York , NY 10028
Voice: 212.650.2010
TTY: 212.570.3828
www.metmuseum.org
Conference information: www.artbeyondsight.org/change/aw-conference-2009.shtml

Comments

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria